TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $557,000 | +57.8% | 7,400 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $353,000 | -97.2% | 7,400 | -96.2% | 0.00% | -97.0% |
| Q3 2021 | $12,808,000 | -4.4% | 192,800 | +12.2% | 0.07% | -4.3% |
| Q2 2021 | $13,404,000 | +0.1% | 171,800 | +21.3% | 0.07% | -7.9% |
| Q1 2021 | $13,394,000 | -21.7% | 141,600 | +0.9% | 0.08% | -26.9% |
| Q4 2020 | $17,108,000 | +11.6% | 140,400 | -20.0% | 0.10% | -7.1% |
| Q3 2020 | $15,323,000 | +24.3% | 175,400 | -8.1% | 0.11% | +115.4% |
| Q2 2020 | $12,324,000 | – | 190,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |